Clinical trial
Trial of Oral Glutamine in Patients With Sickle Cell Anemia
NCT00131508 · St. Jude Children's Research Hospital, Other · Terminated
Key facts
| NCT number | NCT00131508 |
|---|---|
| Title | Trial of Oral Glutamine in Patients With Sickle Cell Anemia |
| Official title | A Randomized Controlled Trial of Oral Glutamine Supplementation Versus a Placebo Supplement in Children With Sickle Cell Anemia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Thrasher Research Fund |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell |
| Intervention type | Drug |
| Interventions | Glutamine, Placebo |
| Enrollment | 27 |
| Start date | May 1, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Aug 18, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: